Your browser doesn't support javascript.
loading
MiR-12200-5p Targets Multiple Members of Wnt Signaling Pathway to Inhibit Osteoblast Differentiation and Bone Formation.
Li, Hui; Yin, Chong; Li, Jingjia; Huang, Qian; Huai, Ying; Chu, Xiaohua; Ji, Mili; Tian, Ye; Qian, Airong; Li, Danming.
Affiliation
  • Li H; Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Yin C; Department of Clinical Laboratory, Laboratory of Epigenetics and RNA Therapy, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
  • Li J; Department of Laboratory Medicine, Translational Medicine Research Center, North Sichuan Medical College, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
  • Huang Q; Department of Human Anatomy, Biological Targeting Laboratory of Breast Cancer, School of Basic Medical Sciences of North Sichuan Medical College, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
  • Huai Y; Laboratory for Bone Metabolism, Xi'an Key Laboratory of Special Medicine and Health Engineering, Key Lab for Space Biosciences and Biotechnology, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China.
  • Chu X; Research Center for Special Medicine and Health Systems Engineering, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China.
  • Ji M; NPU-UAB Joint Laboratory for Bone Metabolism, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China.
  • Tian Y; Laboratory for Bone Metabolism, Xi'an Key Laboratory of Special Medicine and Health Engineering, Key Lab for Space Biosciences and Biotechnology, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China.
  • Qian A; Research Center for Special Medicine and Health Systems Engineering, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China.
  • Li D; NPU-UAB Joint Laboratory for Bone Metabolism, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, China.
Article de En | MEDLINE | ID: mdl-36856174
BACKGROUND: Osteoporosis is widespread and has become an emerging problem in the elderly. MicroRNAs could affect osteoblast differentiation and further regulate the occurrence of osteoporosis by targeting osteogenic differentiation signaling pathways. Our screening study found that miR-12200-5p simultaneously targeted six important factors within the Wnt signaling pathway (Apc, Tcf4, Tcf7, Wnt3a, Wnt5a, and Lrp6), indicating that miR-12200-5p might function as a strong regulator of this pathway. Since the Wnt pathway exists as one of the most essential pathways for osteogenic differentiation, miR-12200-5p may have an important role in the development of osteoporosis. OBJECTIVE: This study intended to explore the regulatory role and corresponding mechanism of miR-12200-5p in osteoblast differentiation. METHODS: We investigated the differentiation of osteoblast after the treatments of miR-12200-5p mimic and inhibitor. The interactions between miR-12200-5p and its target genes were also detected. Furthermore, the rescue effect of miR-12200-5p inhibitor on osteoporosis was evaluated using an ovariectomized osteoporosis mouse model. RESULTS: MiR-12200-5p significantly inhibited osteoblast differentiation, and bound with the 3'-UTR sequences of its target genes (Apc, Tcf4, Tcf7, Wnt3a, Wnt5a, and Lrp6) to reduce the expressions of these genes. The inhibition of miR-12200-5p would almost fully alleviate postmenopausal osteoporosis. CONCLUSION: MiR-12200-5p could strongly repress osteoblast differentiation and bone formation by targeting multiple members of the Wnt signaling pathway simultaneously. The study supplemented the theoretical and experimental basis for researching the mechanism of osteogenic differentiation and inspired the development of novel therapeutic strategies for osteoporosis.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ostéoporose / MicroARN Type d'étude: Prognostic_studies Limites: Animals Langue: En Journal: Endocr Metab Immune Disord Drug Targets Sujet du journal: ALERGIA E IMUNOLOGIA / ENDOCRINOLOGIA / METABOLISMO / TERAPIA POR MEDICAMENTOS Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Émirats arabes unis

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ostéoporose / MicroARN Type d'étude: Prognostic_studies Limites: Animals Langue: En Journal: Endocr Metab Immune Disord Drug Targets Sujet du journal: ALERGIA E IMUNOLOGIA / ENDOCRINOLOGIA / METABOLISMO / TERAPIA POR MEDICAMENTOS Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Émirats arabes unis